Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A24038 | 23292294 | Clin Exp Med | Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease. | 2013 | Details |
| A24051 | 23278318 | Diabet Med | Assessment of the fatty liver index as an indicator of hepatic steatosis for predicting incident diabetes independently of insulin resistance in a Korean population. | 2013 | Details |
| A24086 | 23238855 | Endocr Rev | Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo. | 2012 | Details |
| A24090 | 23236362 | PLoS One | Improved glycaemia correlates with liver fat reduction in obese, type 2 diabetes, patients given glucagon-like peptide-1 (GLP-1) receptor agonists. | 2012 | Details |
| A24091 | 23236229 | World J Gastroenterol | Way back for fructose and liver metabolism: bench side to molecular insights. | 2012 | Details |
| A24118 | 23213066 | Hepatology | Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in Korean men: 5-year prospective cohort study. | 2013 | Details |
| A24120 | 23212097 | Lab Invest | Spontaneous onset of nonalcoholic steatohepatitis and hepatocellular carcinoma in a mouse model of metabolic syndrome. | 2012 | Details |
| A24128 | 23203089 | Int J Mol Sci | Non-alcoholic fatty liver disease is not related to the incidence of diabetic nephropathy in Type 2 Diabetes. | 2012 | Details |
| A24133 | 23197236 | Med Sci Monit | The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease. | 2012 | Details |
| A24145 | 23182413 | Epilepsy Res | The novel insulin resistance parameters RBP4 and GLP-1 in patients treated with valproic acid: just a sidestep? | 2012 | Details |
| A24161 | 23165995 | Mol Nutr Food Res | miRNAs, polyphenols, and chronic disease. | 2012 | Details |
| A24163 | 23163663 | Aliment Pharmacol Ther | Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program. | 2012 | Details |
| A24174 | 23148186 | Ther Adv Endocrinol Metab | An Endocrine Perspective of Nonalcoholic Fatty Liver Disease (NAFLD). | 2011 | Details |
| A24181 | 23142622 | J Hepatol | Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease. | 2012 | Details |
| A24193 | 23134937 | BMC Pediatr | Ethnicity and elevated liver transaminases among newly diagnosed children with type 2 diabetes. | 2012 | Details |
| A24203 | 23126674 | Transpl Int | Metabolic syndrome and its association with fatty liver disease after orthotopic liver transplantation. | 2012 | Details |
| A24209 | 23120807 | Acta Med Croatica | [Relationship between nonalcoholic fatty liver disease markers and renal function in patients with type 1 diabetes]. | 2011 | Details |
| A24211 | 23117851 | Medicine (Baltimore) | Nonalcoholic fatty liver disease in lean individuals in the United States. | 2012 | Details |
| A24213 | 23113131 | Iran J Public Health | Relationship between Serum Aminotransferase Levels and Metabolic Disorders in Northern China. | 2012 | Details |
| A24224 | 23107446 | J Dig Dis | Suboptimal performance of simple noninvasive tests for advanced fibrosis in Chinese patients with nonalcoholic fatty liver disease. | 2012 | Details |
| A24248 | 23077931 | Rev Med Chir Soc Med Nat Iasi | The central role of the non alcoholic fatty liver disease in metabolic syndrome. | 2012 | Details |
| A24250 | 23075940 | Curr Opin Clin Nutr Metab Care | Vitamin E and nonalcoholic fatty liver disease. | 2012 | Details |
| A24259 | 23068074 | Mol Aspects Med | Innate immune activation in obesity. | 2012 | Details |
| A24272 | 23060397 | Hepatobiliary Pancreat Dis Int | Serum parameters predict the severity of ultrasonographic findings in non-alcoholic fatty liver disease. | 2012 | Details |
| A24273 | 23059409 | J Clin Gastroenterol | Hepatic steatosis in human immunodeficiency virus: a prospective study in patients without viral hepatitis, diabetes, or alcohol abuse. | 2013 | Details |
| A24275 | 23057494 | Aliment Pharmacol Ther | Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease. | 2012 | Details |
| A24277 | 23054903 | J Gastrointest Surg | Metabolic disorders, non-alcoholic fatty liver disease and major liver resection: an underestimated perioperative risk. | 2012 | Details |
| A24296 | 23028811 | PLoS One | Glucose intolerance and the amount of visceral adipose tissue contribute to an increase in circulating triglyceride concentrations in Caucasian obese females. | 2012 | Details |
| A24300 | 23026517 | Biomed Environ Sci | The prevalence of nonalcoholic fatty liver disease and its association with lifestyle/dietary habits among university faculty and staff in Chengdu. | 2012 | Details |
| A24334 | 22989165 | J Gastroenterol Hepatol | Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus. | 2013 | Details |
| A24355 | 22973538 | G3 (Bethesda) | Quantitative trait loci affecting liver fat content in mice. | 2012 | Details |
| A24373 | 22961556 | Hepatology | Solute carrier family 2 member 1 is involved in the development of nonalcoholic fatty liver disease. | 2012 | Details |
| A24375 | 22960565 | J Proteomics | Proteomic analysis of liver mitochondria of apolipoprotein E knockout mice treated with metformin. | 2012 | Details |
| A24377 | 22959662 | Atherosclerosis | Liver fat content is associated with an increase in cholesterol synthesis independent of statin therapy use in patients with type 2 diabetes. | 2012 | Details |
| A24378 | 22958053 | Aliment Pharmacol Ther | Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population-based study. | 2012 | Details |
| A24379 | 22955994 | Diabetologia | Protection from non-alcoholic steatohepatitis and liver tumourigenesis in high fat-fed insulin receptor substrate-1-knockout mice despite insulin resistance. | 2012 | Details |
| A24384 | 22950794 | Nucleic Acid Ther | Role of regulatory micro RNAs in type 2 diabetes mellitus-related inflammation. | 2012 | Details |
| A24386 | 22950055 | Diabetes Metab J | GLP-1 Receptor Agonist and Non-Alcoholic Fatty Liver Disease. | 2012 | Details |
| A24403 | 22933860 | Gastroenterol Hepatol (N Y) | Hepatitis C virus infection and nonalcoholic steatohepatitis. | 2012 | Details |
| A24411 | 22927782 | ScientificWorldJournal | The effectiveness of liraglutide in nonalcoholic fatty liver disease patients with type 2 diabetes mellitus compared to sitagliptin and pioglitazone. | 2012 | Details |
| A24414 | 22923210 | J Gastrointest Surg | Influence of hepatic parenchymal histology on outcome following right hepatic trisectionectomy. | 2012 | Details |
| A24422 | 22913901 | Postgrad Med | Managing diabetes in patients with chronic liver disease. | 2012 | Details |
| A24425 | 22911170 | J Gastroenterol | Clinicopathological features of liver injury in patients with type 2 diabetes mellitus and comparative study of histologically proven nonalcoholic fatty liver diseases with or without type 2 diabetes mellitus. | 2012 | Details |
| A24426 | 22908056 | Hormones (Athens) | The pluses and minuses of bariatric surgery for morbid obesity: An endocrinological perspective. | 2013 | Details |
| A24438 | 22893453 | Endocr J | Fatty liver as a consequence and cause of insulin resistance: lessons from type 2 diabetic liver. | 2012 | Details |
| A24439 | 22892494 | Intern Med | Long-term branched-chain amino acid supplementation improves glucose tolerance in patients with nonalcoholic steatohepatitis-related cirrhosis. | 2012 | Details |
| A24481 | 22851489 | J Clin Endocrinol Metab | Increased tenascin C and Toll-like receptor 4 levels in visceral adipose tissue as a link between inflammation and extracellular matrix remodeling in obesity. | 2012 | Details |
| A24487 | 22846353 | Clin Calcium | [Magnesium and liver]. | 2012 | Details |
| A24490 | 22844567 | Gut Liver | Effect of nonalcoholic Fatty liver disease on the development of type 2 diabetes in nonobese, nondiabetic korean men. | 2012 | Details |
| A24491 | 22843768 | Radiology | Intravoxel incoherent motion diffusion-weighted imaging in nonalcoholic fatty liver disease: a 3.0-T MR study. | 2012 | Details |
| A24535 | 22795319 | Clin Res Hepatol Gastroenterol | Does fructose consumption contribute to non-alcoholic fatty liver disease? | 2012 | Details |
| A24538 | 22790124 | Intern Med | Non-alcoholic fatty liver disease is an independent predictor for macroangiopathy in Japanese type 2 diabetic patients: a cross-sectional study. | 2012 | Details |
| A24544 | 22770479 | BMC Gastroenterol | Predicting incident fatty liver using simple cardio-metabolic risk factors at baseline. | 2012 | Details |
| A24547 | 22768812 | Rev Med Inst Mex Seguro Soc | Hepatic steatosis and type 2 diabetes mellitus in health workers. | 2012 | Details |
| A24552 | 22760235 | JAMA | Management of nonalcoholic fatty liver disease: a 60-year-old man with probable nonalcoholic fatty liver disease: weight reduction, liver biopsy, or both? | 2012 | Details |
| A24562 | 22749135 | J Nutr Biochem | The role of dietary fatty acids in the pathology of metabolic syndrome. | 2012 | Details |
| A24564 | 22746301 | Curr Drug Metab | Drug disposition in pathophysiological conditions. | 2012 | Details |
| A24572 | 22738690 | J Cardiol | The association between impaired collateral circulation and non-alcoholic fatty liver in patients with severe coronary artery disease. | 2012 | Details |
| A24575 | 22735605 | Eur J Gastroenterol Hepatol | How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease. | 2012 | Details |
| A24612 | 22691891 | Minerva Endocrinol | Is NAFLD an independent risk factor for increased IMT in T2DM? | 2012 | Details |
| A24630 | 22673296 | Endocr J | A case of glycogenic hepatopathy developed in a patient with new-onset fulminant type 1 diabetes: the role of image modalities in diagnosing hepatic glycogen deposition including gradient-dual-echo MRI. | 2012 | Details |
| A24634 | 22672330 | Diabet Med | Dorothy Hodgkin Lecture 2012: non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management. | 2012 | Details |
| A24635 | 22672067 | Australas J Dermatol | The increased prevalence of non-alcoholic fatty liver disease in psoriatic patients: a study from South India. | 2012 | Details |
| A24658 | 25755421 | J Clin Exp Hepatol | Non-alcoholic Fatty Liver Disease: East Versus West. | 2012 | Details |
| A24673 | 22619360 | Endocrinology | Endoplasmic reticulum stress induces the expression of fetuin-A to develop insulin resistance. | 2012 | Details |
| A24685 | 22610995 | Obes Surg | Impact of weight-loss surgery and diabetes status on serum ALT levels. | 2012 | Details |
| A24695 | 22588935 | Nan Fang Yi Ke Da Xue Xue Bao | [Hepatic SIRT1 and UCP2 expressions in rats with type 2 diabetes mellitus and nonalcoholic fatty liver]. | 2012 | Details |
| A24707 | 22576780 | Diabetes Metab Res Rev | Diabetic fatty liver disease is associated with specific changes in blood-borne markers. | 2012 | Details |
| A24724 | 22560210 | Cell Metab | Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance. | 2012 | Details |
| A24740 | 22546234 | Eur J Pharmacol | Effect of valsartan on the pathological progression of hepatic fibrosis in rats with type 2 diabetes. | 2012 | Details |
| A24747 | 22541252 | Gastroenterol Hepatol | [Influence of non-alcoholic fatty liver disease on cardiovascular disease]. | 2012 | Details |
| A24759 | 22531091 | Int J Obes (Lond) | Effect of intrauterine growth retardation on liver and long-term metabolic risk. | 2012 | Details |
| A24771 | 22519948 | Scand J Gastroenterol | A prospective evaluation of the role of transient elastography for the detection of hepatic fibrosis in type 2 diabetes without overt liver disease. | 2012 | Details |
| A24781 | 22505194 | Hepatology | Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis. | 2012 | Details |
| A24785 | 22498245 | Best Pract Res Clin Endocrinol Metab | Metabolic insights from extreme human insulin resistance phenotypes. | 2012 | Details |
| A24789 | 22490991 | J Endocrinol Invest | Non-alcoholic fatty liver disease is independently associated with left ventricular hypertrophy in hypertensive Type 2 diabetic individuals. | 2012 | Details |
| A24812 | 22364603 | Actas Dermosifiliogr | [Integrated approach to comorbidity in patients with psoriasis.Working Group on Psoriasis-associated Comorbidities]. | 2012 | Details |
| A24814 | 22468051 | Indian J Clin Biochem | Role of cytokines in the pathogenesis of non-alcoholic Fatty liver disease. | 2011 | Details |
| A24819 | 22467259 | Hepatology | Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes. | 2012 | Details |
| A24832 | 22450341 | Hormones (Athens) | Adiponectin: regulation of its production and its role in human diseases. | 2012 | Details |
| A24847 | 22434756 | Pediatr Obes | Influence of elevated liver fat on circulating adipocytokines and insulin resistance in obese Hispanic adolescents. | 2012 | Details |
| A24872 | 22418885 | Semin Liver Dis | Dyslipidemia in patients with nonalcoholic fatty liver disease. | 2012 | Details |
| A24883 | 22397032 | Adv Clin Chem | Fetuin-A and the cardiovascular system. | 2012 | Details |
| A24886 | 22395062 | J Clin Gastroenterol | Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease. | 2012 | Details |
| A24894 | 22385956 | Cell | Mechanisms for insulin resistance: common threads and missing links. | 2012 | Details |
| A24895 | 22385608 | Kaohsiung J Med Sci | Severity of fatty liver on ultrasound correlates with metabolic and cardiovascular risk. | 2012 | Details |
| A24899 | 22381945 | Phytomedicine | Prevention of free fatty acid-induced lipid accumulation, oxidative stress, and cell death in primary hepatocyte cultures by a Gynostemma pentaphyllum extract. | 2012 | Details |
| A24906 | 22374640 | Diabetes Care | Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD). | 2012 | Details |
| A24919 | 22360487 | Curr Med Chem | Non-alcoholic steatohepatitis: what can we learn from animal models? | 2012 | Details |
| A24936 | 22340817 | BMC Gastroenterol | Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease. | 2012 | Details |
| A24937 | 22340678 | Liver Int | Identification of liver proteins altered by type 2 diabetes mellitus in obese subjects. | 2012 | Details |
| A24951 | 22326434 | Gastroenterology | Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. | 2012 | Details |
| A24952 | 22319959 | Acta Gastroenterol Belg | Risk factors for non-alcoholic fatty liver disease in a Chinese population. | 2011 | Details |
| A24962 | 22308697 | Zhongguo Zhong Yao Za Zhi | [Research on therapeutic effect and hemorrheology change of berberine in new diagnosed patients with type 2 diabetes combining nonalcoholic fatty liver disease]. | 2011 | Details |
| A24973 | 22291824 | Arch Med Sci | Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study. | 2011 | Details |
| A24988 | 22274553 | Acta Diabetol | Factors that influence basal insulin requirement in type 2 diabetes. | 2012 | Details |
| A25023 | 22239625 | Curr Vasc Pharmacol | Non-alcoholic fatty liver disease in type 2 diabetes: pathogenesis and treatment options. | 2012 | Details |
| A25031 | 22228717 | Diabetes | TIMP3 overexpression in macrophages protects from insulin resistance, adipose inflammation, and nonalcoholic fatty liver disease in mice. | 2012 | Details |
| A25034 | 22227333 | Eur J Pharmacol | Flavangenol (pine bark extract) and its major component procyanidin B1 enhance fatty acid oxidation in fat-loaded models. | 2011 | Details |
| A25048 | 22215535 | IUBMB Life | Association of nonalcoholic fatty liver disease with a single nucleotide polymorphism on the gene encoding leptin receptor. | 2012 | Details |